Synedgen uses the science of glycomics – the study of complex sugar structure and function – to discover and develop ultra-purified therapeutic polysaccharides that are soluble, active, and targeted in the human body. Our new molecular entities are designed to alter the progression of diseases and improve the lives of patients.
See our lead programs
Learn how our therapeutics work
Partner with us to develop and scale breakthrough therapeutics